🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase III non-inferiority trial targeting a specific subset...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07432178
Treatments Being Tested
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-29
Trial ID
NCT07582315
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a 2-arm parallel pragmatic randomized controlled trial that will co...
Status
Completed
Location
Jaseng Hospital of Korean Medicine
Start Date
2021-07-09
Trial ID
NCT04833270
Treatments Being Tested
This is a prospective, randomized, open-label, multicenter phase III study ...
Status
Recruiting
Location
Zhimin Cancer Shao
Start Date
2024-04-02
Trial ID
NCT06341621
Treatments Being Tested
The purpose of this study was to demonstrate superiority of treatment with ...
Status
Completed
Location
Rocky Mountain Cancer Centers 1800 Williams Street, Suite 100
Start Date
2015-12-28
Trial ID
NCT02625623
Treatments Being Tested
Researchers are looking for new ways to treat people with endometrial cance...
Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Start Date
2023-12-06
Trial ID
NCT06132958
Treatments Being Tested
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested